iBio (IBIO) News Today $0.59 0.00 (-0.03%) Closing price 08/8/2025 04:00 PM EasternExtended Trading$0.59 0.00 (-0.20%) As of 08/8/2025 07:58 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock IBIO Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period iBio Faces Nasdaq Delisting Notice for Stock PriceAugust 1, 2025 | tipranks.comPharos IBio Co Ltd Share Price - Investing.com UKJune 30, 2025 | uk.investing.comiBio Announces Conference Call to Review Myostatin and Activin E Antibody Data and Reveal Third Target in AstralBio Collaboration on June 24 | NasdaqJune 24, 2025 | nasdaq.comiBio Advances Obesity Care with Antibody TherapiesJune 24, 2025 | tipranks.comiBio and AstralBio Unveil Obesity Program with Novel Amylin Agonist Antibody Demonstrating Promising In Vivo ResultsJune 24, 2025 | globenewswire.comiBio Presents Next-Generation Obesity and Cardiometabolic Pipeline Candidates on June 24 Conference CallJune 23, 2025 | globenewswire.comiBio Extends Promissory Note Maturity to 2026June 18, 2025 | tipranks.comiBio Initiates Non-Human Primate Study of First-in-Class Activin E Antibody Following Positive Preclinical Data Demonstrating Prevention in Weight Regain After GLP-1 TreatmentJune 16, 2025 | globenewswire.comiBio’s First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical ModelMay 5, 2025 | finance.yahoo.comiBio's First-in-Class Activin E Antibody Achieves >26% Fat Reduction Without Muscle Loss and Shows Synergy with GLP-1s in Preclinical ModelMay 5, 2025 | globenewswire.comiBio Reports Fiscal Third Quarter 2025 Financial ResultsMay 2, 2025 | globenewswire.comiBio, Inc.: iBio Raises $6.2 Million Through Warrant Inducement TransactionApril 30, 2025 | finanznachrichten.deiBio, Inc. Announces Agreement to Exercise Existing Warrants for $6.2 Million in Gross ProceedsApril 29, 2025 | quiverquant.comQiBio Raises $6.2 Million Through Warrant Inducement TransactionApril 29, 2025 | globenewswire.comiBio Enters Licensing Agreement for Obesity TreatmentApril 22, 2025 | tipranks.comiBio Expands Cardiometabolic and Obesity Pipeline through Licensing of First-in-Class Antibody Targeting Activin E from AstralBioApril 22, 2025 | globenewswire.comiBio Stock Plummets Despite Positive Data On Weight-Loss Treatment Antibody: Retail Stays BearishApril 8, 2025 | msn.comiBio Highlights Advancements in Obesity Antibody ProgramsApril 8, 2025 | tipranks.comiBio Announces IBIO-600 Non-Human Primate Data Showing Extended Half-Life and Muscle Growth, and Interim In Vivo Results for First-in-Class Activin E Antibody, Advancing Cardiometabolic and Obesity PipelineApril 7, 2025 | globenewswire.comiBio, Inc. Advances in Therapeutics and LeadershipFebruary 21, 2025 | tipranks.comiBio to Begin Trading on the Nasdaq Stock ExchangeFebruary 19, 2025 | globenewswire.comIs Ibio, Inc. (IBIO) Among Stocks Insiders Are Buying This Year?February 17, 2025 | msn.comiBio Reports Fiscal Second Quarter 2025 Financial ResultsFebruary 10, 2025 | globenewswire.comiBio Inc. stock falls Monday, still outperforms marketJanuary 27, 2025 | marketwatch.comFelipe Duran Purchases 9,191 Shares of iBio, Inc. (NYSE:IBIO) StockJanuary 14, 2025 | insidertrades.comiBio closes private placement offering with board members, officersJanuary 13, 2025 | markets.businessinsider.comiBio director buys $500K in common stockJanuary 13, 2025 | markets.businessinsider.comiBio Advances Antibody Development for Obesity TreatmentJanuary 10, 2025 | tipranks.comiBio Discovers Novel Antibody Targeting Activin E in Collaboration with AstralBioJanuary 7, 2025 | finance.yahoo.comiBio Inc. stock rises Monday, still underperforms marketJanuary 6, 2025 | marketwatch.comiBio Expands Pipeline with New Antibody AgreementJanuary 2, 2025 | tipranks.comiBio Expands Cardiometabolic and Obesity Program with Anti-Myostatin Antibody Discovered Using its Proprietary Platform, In-Licensed from AstralBioJanuary 2, 2025 | globenewswire.comiBio Inc. stock falls Wednesday, still outperforms marketDecember 18, 2024 | marketwatch.comLUCID CAPITAL MARKETS Initiates Coverage of iBio (IBIO) with Buy RecommendationDecember 18, 2024 | msn.comiBio Reports Fiscal First Quarter 2025 Financial ResultsNovember 12, 2024 | globenewswire.comDeveloping environmentally friendly wood fiber boardsNovember 8, 2024 | msn.comiBio Unveils AI-Driven Antibody Discovery StrategyOctober 23, 2024 | markets.businessinsider.comiBio and AstralBio Provide Update on Myostatin Program for ObesityOctober 10, 2024 | finance.yahoo.comStock market today: Wall Street rises toward more records as markets rally worldwideSeptember 27, 2024 | msn.comiBio Reports Fiscal Year 2024 Financial Results and Provides Corporate UpdateSeptember 20, 2024 | globenewswire.comMerck & Co., Inc. (MRK) Bank of America Global Healthcare Conference (Transcript)September 18, 2024 | seekingalpha.comiBio to Participate in Upcoming Investor ConferencesSeptember 3, 2024 | globenewswire.comiBio Expands Executive Leadership Team with Appointment of Kristi Sarno as Senior Vice President of Business DevelopmentAugust 12, 2024 | globenewswire.comStock Market Sell-Off: This Is the Single Best Investing Move You Can Make Right NowAugust 9, 2024 | fool.comObesity Clinical Trial Pipeline Appears Robust With 80+ Key Pharma Companies Actively Working in the Therapeutics Segment | DelveInsightAugust 6, 2024 | finance.yahoo.com0JV0.DU,0P0001O4RT,0 (0JV0.DU)July 23, 2024 | sg.finance.yahoo.comiBio Closes Sale of Manufacturing Facility in TexasJune 3, 2024 | globenewswire.comiBio, Inc.: iBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate UpdateMay 14, 2024 | finanznachrichten.deiBio Reports Fiscal Third Quarter 2024 Financial Results and Provides Corporate UpdateMay 13, 2024 | globenewswire.com3 Healthcare Stocks Short Sellers Are Prescribing for TroubleApril 5, 2024 | investorplace.com Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address IBIO Media Mentions By Week IBIO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IBIO News Sentiment▼0.000.50▲Average Medical News Sentiment IBIO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IBIO Articles This Week▼00▲IBIO Articles Average Week Get iBio News Delivered to You Automatically Sign up to receive the latest news and ratings for IBIO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies ACRV News GRCE News EGRX News COEP News LVTX News SLGL News STTK News OVID News HYPD News ENLV News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NYSE:IBIO) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding iBio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share iBio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free IBIO Stock Alerts